Suppr超能文献

利用聚合物共混物中的固体分散体来调整氟康唑的释放速率。

Tailoring the release rates of fluconazole using solid dispersions in polymer blends.

作者信息

Papageorgiou George Z, Bikiaris Dimitrios, Kanaze Feras I, Karavas Evangelos, Stergiou Anagnostis, Georgarakis Emmanouil

机构信息

Laboratory of Organic Chemical Technology, Chemistry Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.

出版信息

Drug Dev Ind Pharm. 2008 Mar;34(3):336-46. doi: 10.1080/03639040701662669.

Abstract

Formulations of the drug Fluconazole with different release characteristics were prepared by dispersing the active pharmaceutical ingredient (API) in various polymeric carriers, and especially in polymer blends. Fluconazole was tested as a model drug with low solubility in water. First solid dispersions in pure polymers were studied. Use of pure polyvinylpyrrolidone (PVP) as carrier even for high drug load (30 wt%) resulted in rapid release. The drug release rates decreased by increasing the API content. The dissolution rate enhancement was attributed to drug amorphization, particle size reduction, and possible improvement of the drug wetting characteristics. Hydroxypropyl methylcellulose (HPMC) gave solid dispersions, from which the release rates of the drug varied from immediate to sustaining. As the drug amount increased, the rates became higher. Similar behavior also was found when Chitosan was used as carrier, with much more controlled rates close to those for sustained release. These differences were mainly attributed to the limited solubility and swelling of HPMC and Chitosan in aquatic media. To study the effectiveness of polymer blends in adjusting the release rates of the drug, solid dispersions in PVP/HPMC and PVP/Chitosan miscible blends were studied. The release rates of Fluconazole were adequately adjusted by differentiating the weight ratio of the polymers in the blends. PVP/HPMC blends with high PVP content can be used for immediate release formulations but PVP/Chitosan blends are inappropriate for such formulations and can only be used for controlled release.

摘要

通过将活性药物成分(API)分散在各种聚合物载体中,特别是在聚合物共混物中,制备了具有不同释放特性的氟康唑制剂。氟康唑作为一种在水中溶解度较低的模型药物进行了测试。首先研究了在纯聚合物中的固体分散体。即使对于高载药量(30 wt%),使用纯聚乙烯吡咯烷酮(PVP)作为载体制备的制剂也会导致药物快速释放。药物释放速率随着API含量的增加而降低。溶出速率的提高归因于药物的无定形化、粒径减小以及药物润湿性的可能改善。羟丙基甲基纤维素(HPMC)制备的固体分散体,其药物释放速率从速释到缓释不等。随着药物量的增加,释放速率变得更高。当壳聚糖用作载体时也发现了类似的行为,其释放速率更可控,接近缓释制剂的释放速率。这些差异主要归因于HPMC和壳聚糖在水性介质中的有限溶解度和溶胀性。为了研究聚合物共混物在调节药物释放速率方面的有效性,研究了PVP/HPMC和PVP/壳聚糖可混溶共混物中的固体分散体。通过区分共混物中聚合物的重量比,可以充分调节氟康唑的释放速率。高PVP含量的PVP/HPMC共混物可用于速释制剂,但PVP/壳聚糖共混物不适用于此类制剂,只能用于控释制剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验